PAREXEL International Corporation Share Price

Equities

20/06/17	PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion	RE
20/06/17	PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion	RE
08/05/17	PAREXEL International : Contract research firm Parexel International explores sale - sources	RE

23/06/19	Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships	BU
12/12/17	PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry	BU
15/11/17	PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry	BU
29/09/17	PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International	BU
18/09/17	PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management	BU

12/11/14

Manager	Title	Age	Since
Peyton Howell CEO	Chief Executive Officer	59	14/05/2024
Jonathan Shough CTO	Chief Tech/Sci/R&D Officer	-	31/10/2022
Michael Crowley ADM	Chief Administrative Officer	-	-

Director	Title	Age	Since
Peyton Howell BRD	Director/Board Member	59	14/05/2024
Eric Liu BRD	Director/Board Member	49	31/10/2021
Sherilyn McCoy CHM	Chairman	67	31/10/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
PAREXEL INTERNATIONAL CORPORATION	-.--%	+0.10%	-	-	0
LONZA GROUP AG	+0.04%	-0.68%	-4.77%	+12.20%	49.48B
IQVIA HOLDINGS INC.	-1.56%	-1.00%	+14.23%	+2.87%	40.07B
BEONE MEDICINES AG	+0.15%	+0.33%	+52.68%	+26.14%	37.55B
CELLTRION, INC.	+1.92%	+1.44%	+23.10%	+42.46%	31.67B
REVOLUTION MEDICINES, INC.	-0.99%	-2.20%	+185.93%	+328.06%	22.74B
MEDPACE HOLDINGS, INC.	-3.01%	-3.74%	+69.03%	+145.51%	16.56B
Average	-0.49%	-0.45%	+56.70%	+92.87%	33.01B
Weighted average by Cap.	-0.34%	-0.28%	+42.49%	+65.21%

Employees

Sector